Kelefiotis D, Bresnahan B A, Stratidakis I, Lianos E A
Department of Medicine, Medical College of Wisconsin, Milwaukee, USA.
Prostaglandins. 1995 May;49(5):269-83. doi: 10.1016/0090-6980(95)00049-g.
Renal glomerular injury frequently results in proliferation of a specialized supporting cell of the glomerular capillary known as the mesangial cell. In various forms of renal injury there is enhanced glomerular synthesis of specific eicosanoids of the arachidonic cyclooxygenase and lipoxygenase pathways including prostaglandin (PG) F2 alpha, thromboxane (Tx) A2, the hydroxyeicosatetraenoic acids 12-HETE and 5-HETE, and the leukotrienes LTB4 and LTD4 and attempts have been made to link these eicosanoids with injury-induced mesangial cell growth. In this study, the growth promoting effect of these eicosanoids on glomerular mesangial cells was correlated with activation of two growth regulatory enzymes: phospholipase C (PLC) and protein kinase C (PKC). PGF2 alpha, and TxA2 endoperoxide analog U-46619, and LTD4 significantly enhanced DNA synthesis [(as assessed by [3H]thymidine (TdR) incorporation)] in relatively quiescent (0.5% serum) mesangial cells, activated PLC [as assessed by increased 1,4,5-inositol tris-phosphate (IP3) generation and diacylglycerol (DAG) synthesis], and activated PKC (as assessed by translocation of the enzyme activity from the cytosol to the membrane). The effect of PGF2 alpha on IP3 generation was not blocked by the TxA2 receptor antagonist, SQ-29,548. PGF2 alpha was the most effective eicosanoid in inducing all three events, and concentrations that enhanced TdR incorporation (1 microM) also activated PLC and PKC. In contrast, concentrations of U-46619 and LTD4 which enhanced TdR incorporation (1 microM), also activated PLC, but were insufficient to also activate PKC. Our observations indicate that the growth-promoting effect of PGF2 alpha, U-46619, and LTD4 can best be correlated with PLC activation. In addition, PGF2 alpha does not mediate PLC activation through binding to the TxA2 receptor.
肾小球损伤常常导致肾小球毛细血管中一种称为系膜细胞的特殊支持细胞增殖。在各种形式的肾损伤中,肾小球中花生四烯酸环氧化酶和脂氧合酶途径的特定类二十烷酸合成增强,包括前列腺素(PG)F2α、血栓素(Tx)A2、羟基二十碳四烯酸12-HETE和5-HETE,以及白三烯LTB4和LTD4,并且人们试图将这些类二十烷酸与损伤诱导的系膜细胞生长联系起来。在本研究中,这些类二十烷酸对肾小球系膜细胞的促生长作用与两种生长调节酶的激活相关:磷脂酶C(PLC)和蛋白激酶C(PKC)。PGF2α、TxA2内过氧化物类似物U-46619和LTD4显著增强相对静止(0.5%血清)系膜细胞中的DNA合成[通过[3H]胸腺嘧啶核苷(TdR)掺入评估],激活PLC[通过增加1,4,5-肌醇三磷酸(IP3)生成和二酰甘油(DAG)合成评估],并激活PKC(通过酶活性从胞质溶胶向膜的转位评估)。PGF2α对IP3生成的作用未被TxA2受体拮抗剂SQ-29548阻断。PGF2α是诱导所有这三种事件最有效的类二十烷酸,增强TdR掺入(1μM)的浓度也激活PLC和PKC。相比之下,增强TdR掺入(1μM)的U-46619和LTD4浓度也激活PLC,但不足以激活PKC。我们的观察结果表明,PGF2α、U-46619和LTD4的促生长作用与PLC激活最相关。此外,PGF2α不通过与TxA2受体结合介导PLC激活。